Skip to main content

RAPT Therapeutics, Inc.

RAPTDelisted Mar 3, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001673772

RAPT Therapeutics, Inc. was delisted on Mar 3, 2026; its insiders filed their last Form 4 on Mar 5, 2026; 106 institutions reported holding it in 13F filings for Q4 2025, worth $1.02B in total; no superinvestor held it.

13F holders, Q3 2022

Institutional positions in RAPT Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
98
+13 vs. Q2 2022
Shares held
30.0M
+249.4K (+0.8%) vs. Q2 2022
Total value
$721.0M
+$178.3M (+32.9%) vs. Q2 2022
New holders
22
38 more added
Sold out
9
20 more reduced

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RAPT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 98 institutions
Q1 2021: 78 institutionsQ2 2021: 109 institutionsQ3 2021: 106 institutionsQ4 2021: 99 institutionsQ1 2022: 85 institutionsQ2 2022: 85 institutionsQ3 2022: 98 institutionsQ4 2022: 95 institutionsQ1 2023: 106 institutionsQ2 2023: 98 institutionsQ3 2023: 96 institutionsQ4 2023: 109 institutionsQ1 2024: 122 institutionsQ2 2024: 103 institutionsQ3 2024: 94 institutionsQ4 2024: 91 institutionsQ1 2025: 92 institutionsQ2 2025: 50 institutionsQ3 2025: 65 institutionsQ4 2025: 106 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2022: $721.0M
Q1 2021: $468.4MQ2 2021: $846.6MQ3 2021: $817.8MQ4 2021: $1.02BQ1 2022: $616.1MQ2 2022: $542.7MQ3 2022: $721.0MQ4 2022: $634.7MQ1 2023: $610.5MQ2 2023: $636.7MQ3 2023: $577.8MQ4 2023: $869.3MQ1 2024: $287.2MQ2 2024: $97.0MQ3 2024: $59.9MQ4 2024: $199.5MQ1 2025: $160.0MQ2 2025: $135.6MQ3 2025: $428.0MQ4 2025: $1.02BQ1 2026: $0Q2 2026: $0
Institutions holding RAPT and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 2025106$1.02B
Q3 202565$428.0M
Q2 202550$135.6M
Q1 202592$160.0M
Q4 202491$199.5M
Q3 202494$59.9M
Q2 2024103$97.0M
Q1 2024122$287.2M
Q4 2023109$869.3M
Q3 202396$577.8M
Q2 202398$636.7M
Q1 2023106$610.5M
Q4 202295$634.7M
Q3 202298$721.0M
Q2 202285$542.7M
Q1 202285$616.1M
Q4 202199$1.02B
Q3 2021106$817.8M
Q2 2021109$846.6M
Q1 202178$468.4M

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding RAPT Therapeutics, Inc.; share changes are against Q2 2022.

Institutions holding RAPT in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Man Group plc0$00.00%–Sold out
Ergoteles LLC0$00.00%−12,600−100.0%Sold out
Two Sigma Investments, LP0$00.00%−11,800−100.0%Sold out
Trustees of the University of Pennsylvania0$00.00%−10,031−100.0%Sold out
Quantbot Technologies LP0$00.00%−5,870−100.0%Sold out
Group One Trading, L.P.0$00.00%−232−100.0%Sold out
Northwestern Mutual Wealth Management Co0$00.00%−12−100.0%Sold out